nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0848	0.111	CbGbCtD
Argatroban—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0767	0.1	CbGbCtD
Argatroban—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0767	0.1	CbGbCtD
Argatroban—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0662	0.0866	CbGbCtD
Argatroban—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0642	0.0841	CbGbCtD
Argatroban—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0581	0.0761	CbGbCtD
Argatroban—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0581	0.0761	CbGbCtD
Argatroban—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0352	0.046	CbGbCtD
Argatroban—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0331	0.0433	CbGbCtD
Argatroban—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0331	0.0433	CbGbCtD
Argatroban—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0299	0.0391	CbGbCtD
Argatroban—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0299	0.0391	CbGbCtD
Argatroban—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0258	0.0338	CbGbCtD
Argatroban—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0251	0.0328	CbGbCtD
Argatroban—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0227	0.0297	CbGbCtD
Argatroban—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0227	0.0297	CbGbCtD
Argatroban—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0217	0.0284	CbGbCtD
Argatroban—F2—endothelium—acquired immunodeficiency syndrome	0.00619	0.166	CbGeAlD
Argatroban—F2—blood plasma—acquired immunodeficiency syndrome	0.00549	0.147	CbGeAlD
Argatroban—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.00222	0.0596	CbGeAlD
Argatroban—F2—lymphoid tissue—acquired immunodeficiency syndrome	0.00214	0.0573	CbGeAlD
Argatroban—F2—digestive system—acquired immunodeficiency syndrome	0.00211	0.0566	CbGeAlD
Argatroban—F2—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.00205	0.11	CbGpPWpGaD
Argatroban—F2—blood—acquired immunodeficiency syndrome	0.00201	0.0539	CbGeAlD
Argatroban—F2—bone marrow—acquired immunodeficiency syndrome	0.00195	0.0522	CbGeAlD
Argatroban—F2—spinal cord—acquired immunodeficiency syndrome	0.00194	0.052	CbGeAlD
Argatroban—F2—lung—acquired immunodeficiency syndrome	0.00176	0.0473	CbGeAlD
Argatroban—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00167	0.0447	CbGeAlD
Argatroban—F2—nervous system—acquired immunodeficiency syndrome	0.00163	0.0438	CbGeAlD
Argatroban—F2—central nervous system—acquired immunodeficiency syndrome	0.00157	0.0422	CbGeAlD
Argatroban—F2—brain—acquired immunodeficiency syndrome	0.00125	0.0335	CbGeAlD
Argatroban—F2—Syndecan-4-mediated signaling events—CXCR4—acquired immunodeficiency syndrome	0.000944	0.0506	CbGpPWpGaD
Argatroban—F2—Syndecan-4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.000944	0.0506	CbGpPWpGaD
Argatroban—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000855	0.0229	CbGeAlD
Argatroban—CYP3A5—blood—acquired immunodeficiency syndrome	0.000815	0.0218	CbGeAlD
Argatroban—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000755	0.0202	CbGeAlD
Argatroban—F2—Syndecan-4-mediated signaling events—CCL5—acquired immunodeficiency syndrome	0.000718	0.0385	CbGpPWpGaD
Argatroban—CYP3A5—lung—acquired immunodeficiency syndrome	0.000714	0.0191	CbGeAlD
Argatroban—F2—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000713	0.0382	CbGpPWpGaD
Argatroban—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000642	0.0172	CbGeAlD
Argatroban—CYP3A4—blood—acquired immunodeficiency syndrome	0.000611	0.0164	CbGeAlD
Argatroban—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.000589	0.00327	CcSEcCtD
Argatroban—Acute coronary syndrome—Ritonavir—acquired immunodeficiency syndrome	0.000588	0.00326	CcSEcCtD
Argatroban—Myocardial infarction—Ritonavir—acquired immunodeficiency syndrome	0.000585	0.00324	CcSEcCtD
Argatroban—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.000582	0.00323	CcSEcCtD
Argatroban—Back pain—Zidovudine—acquired immunodeficiency syndrome	0.00058	0.00322	CcSEcCtD
Argatroban—Urinary tract infection—Ritonavir—acquired immunodeficiency syndrome	0.00058	0.00322	CcSEcCtD
Argatroban—Pneumonia—Saquinavir—acquired immunodeficiency syndrome	0.000577	0.0032	CcSEcCtD
Argatroban—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.000571	0.00317	CcSEcCtD
Argatroban—Haematuria—Ritonavir—acquired immunodeficiency syndrome	0.000569	0.00315	CcSEcCtD
Argatroban—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.000562	0.00312	CcSEcCtD
Argatroban—Urinary tract infection—Saquinavir—acquired immunodeficiency syndrome	0.000558	0.0031	CcSEcCtD
Argatroban—Pain—Didanosine—acquired immunodeficiency syndrome	0.000554	0.00308	CcSEcCtD
Argatroban—Infection—Abacavir—acquired immunodeficiency syndrome	0.000551	0.00306	CcSEcCtD
Argatroban—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.000549	0.00305	CcSEcCtD
Argatroban—Back pain—Indinavir—acquired immunodeficiency syndrome	0.000539	0.00299	CcSEcCtD
Argatroban—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.000538	0.00299	CcSEcCtD
Argatroban—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.000535	0.00297	CcSEcCtD
Argatroban—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.00053	0.00294	CcSEcCtD
Argatroban—F2—IL1 and megakaryotyces in obesity—IFNG—acquired immunodeficiency syndrome	0.00053	0.0284	CbGpPWpGaD
Argatroban—Cough—Zidovudine—acquired immunodeficiency syndrome	0.000523	0.0029	CcSEcCtD
Argatroban—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000518	0.00287	CcSEcCtD
Argatroban—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.000518	0.00287	CcSEcCtD
Argatroban—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.000515	0.00286	CcSEcCtD
Argatroban—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000513	0.00284	CcSEcCtD
Argatroban—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000513	0.00284	CcSEcCtD
Argatroban—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.00051	0.00283	CcSEcCtD
Argatroban—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.00051	0.00283	CcSEcCtD
Argatroban—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.000503	0.00279	CcSEcCtD
Argatroban—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000503	0.00279	CcSEcCtD
Argatroban—Pain—Nevirapine—acquired immunodeficiency syndrome	0.000499	0.00277	CcSEcCtD
Argatroban—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000497	0.00276	CcSEcCtD
Argatroban—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000496	0.0133	CbGeAlD
Argatroban—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000495	0.00275	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.000495	0.0265	CbGpPWpGaD
Argatroban—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000494	0.00274	CcSEcCtD
Argatroban—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.000493	0.00274	CcSEcCtD
Argatroban—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.000488	0.0027	CcSEcCtD
Argatroban—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000487	0.0027	CcSEcCtD
Argatroban—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000487	0.0027	CcSEcCtD
Argatroban—Cough—Indinavir—acquired immunodeficiency syndrome	0.000486	0.0027	CcSEcCtD
Argatroban—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000486	0.0027	CcSEcCtD
Argatroban—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000486	0.0027	CcSEcCtD
Argatroban—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.000483	0.00268	CcSEcCtD
Argatroban—Pain—Stavudine—acquired immunodeficiency syndrome	0.000481	0.00267	CcSEcCtD
Argatroban—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000481	0.00267	CcSEcCtD
Argatroban—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00048	0.00267	CcSEcCtD
Argatroban—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000479	0.00266	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000478	0.0256	CbGpPWpGaD
Argatroban—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000478	0.0128	CbGeAlD
Argatroban—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000478	0.00265	CcSEcCtD
Argatroban—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000477	0.00265	CcSEcCtD
Argatroban—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000475	0.00263	CcSEcCtD
Argatroban—Pain—Abacavir—acquired immunodeficiency syndrome	0.000474	0.00263	CcSEcCtD
Argatroban—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000468	0.00259	CcSEcCtD
Argatroban—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.000465	0.00258	CcSEcCtD
Argatroban—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000462	0.00256	CcSEcCtD
Argatroban—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000461	0.00256	CcSEcCtD
Argatroban—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000461	0.00256	CcSEcCtD
Argatroban—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00046	0.00255	CcSEcCtD
Argatroban—Cough—Efavirenz—acquired immunodeficiency syndrome	0.00046	0.00255	CcSEcCtD
Argatroban—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.000457	0.00254	CcSEcCtD
Argatroban—F2—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.000455	0.0244	CbGpPWpGaD
Argatroban—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000453	0.00252	CcSEcCtD
Argatroban—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000452	0.00251	CcSEcCtD
Argatroban—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000451	0.0025	CcSEcCtD
Argatroban—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000448	0.00249	CcSEcCtD
Argatroban—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000448	0.00249	CcSEcCtD
Argatroban—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000448	0.00249	CcSEcCtD
Argatroban—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000446	0.00248	CcSEcCtD
Argatroban—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000446	0.00248	CcSEcCtD
Argatroban—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000446	0.00247	CcSEcCtD
Argatroban—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000445	0.00247	CcSEcCtD
Argatroban—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000445	0.00247	CcSEcCtD
Argatroban—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000444	0.00246	CcSEcCtD
Argatroban—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00044	0.00244	CcSEcCtD
Argatroban—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000438	0.00243	CcSEcCtD
Argatroban—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000438	0.00243	CcSEcCtD
Argatroban—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000436	0.00242	CcSEcCtD
Argatroban—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000434	0.00241	CcSEcCtD
Argatroban—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000433	0.00241	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000432	0.0231	CbGpPWpGaD
Argatroban—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000431	0.00239	CcSEcCtD
Argatroban—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00043	0.00238	CcSEcCtD
Argatroban—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000429	0.00238	CcSEcCtD
Argatroban—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000422	0.00234	CcSEcCtD
Argatroban—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000422	0.00234	CcSEcCtD
Argatroban—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00042	0.00233	CcSEcCtD
Argatroban—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000418	0.00232	CcSEcCtD
Argatroban—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000418	0.00232	CcSEcCtD
Argatroban—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000416	0.00231	CcSEcCtD
Argatroban—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000415	0.0023	CcSEcCtD
Argatroban—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000415	0.0023	CcSEcCtD
Argatroban—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000414	0.0023	CcSEcCtD
Argatroban—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000412	0.00229	CcSEcCtD
Argatroban—Rash—Didanosine—acquired immunodeficiency syndrome	0.000409	0.00227	CcSEcCtD
Argatroban—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000409	0.00227	CcSEcCtD
Argatroban—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000409	0.00227	CcSEcCtD
Argatroban—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000408	0.00227	CcSEcCtD
Argatroban—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000407	0.00226	CcSEcCtD
Argatroban—Headache—Didanosine—acquired immunodeficiency syndrome	0.000406	0.00225	CcSEcCtD
Argatroban—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000406	0.00225	CcSEcCtD
Argatroban—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000403	0.00224	CcSEcCtD
Argatroban—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000401	0.00223	CcSEcCtD
Argatroban—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000401	0.00222	CcSEcCtD
Argatroban—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.0004	0.00222	CcSEcCtD
Argatroban—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000399	0.00221	CcSEcCtD
Argatroban—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000397	0.0022	CcSEcCtD
Argatroban—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000393	0.00218	CcSEcCtD
Argatroban—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000391	0.00217	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000391	0.0209	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.00039	0.0209	CbGpPWpGaD
Argatroban—Pain—Indinavir—acquired immunodeficiency syndrome	0.000389	0.00216	CcSEcCtD
Argatroban—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000389	0.00216	CcSEcCtD
Argatroban—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000387	0.00215	CcSEcCtD
Argatroban—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000387	0.00215	CcSEcCtD
Argatroban—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000386	0.00214	CcSEcCtD
Argatroban—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000385	0.00214	CcSEcCtD
Argatroban—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000385	0.00214	CcSEcCtD
Argatroban—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000384	0.00213	CcSEcCtD
Argatroban—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000384	0.00213	CcSEcCtD
Argatroban—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000383	0.00213	CcSEcCtD
Argatroban—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000382	0.00212	CcSEcCtD
Argatroban—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000379	0.00211	CcSEcCtD
Argatroban—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000378	0.0021	CcSEcCtD
Argatroban—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000375	0.00208	CcSEcCtD
Argatroban—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000373	0.00207	CcSEcCtD
Argatroban—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000373	0.00207	CcSEcCtD
Argatroban—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000372	0.00207	CcSEcCtD
Argatroban—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000372	0.00206	CcSEcCtD
Argatroban—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000371	0.00206	CcSEcCtD
Argatroban—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000371	0.00206	CcSEcCtD
Argatroban—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000371	0.00206	CcSEcCtD
Argatroban—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000369	0.00205	CcSEcCtD
Argatroban—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000368	0.00204	CcSEcCtD
Argatroban—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000368	0.00204	CcSEcCtD
Argatroban—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000368	0.00204	CcSEcCtD
Argatroban—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000367	0.00204	CcSEcCtD
Argatroban—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000367	0.00203	CcSEcCtD
Argatroban—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000367	0.00203	CcSEcCtD
Argatroban—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000365	0.00203	CcSEcCtD
Argatroban—F2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000364	0.0195	CbGpPWpGaD
Argatroban—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000364	0.00202	CcSEcCtD
Argatroban—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000364	0.00202	CcSEcCtD
Argatroban—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000362	0.00201	CcSEcCtD
Argatroban—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00036	0.002	CcSEcCtD
Argatroban—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00036	0.002	CcSEcCtD
Argatroban—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000359	0.00199	CcSEcCtD
Argatroban—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000358	0.00199	CcSEcCtD
Argatroban—F2—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	0.000357	0.0191	CbGpPWpGaD
Argatroban—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000356	0.00198	CcSEcCtD
Argatroban—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000356	0.00197	CcSEcCtD
Argatroban—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000355	0.00197	CcSEcCtD
Argatroban—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000355	0.00197	CcSEcCtD
Argatroban—Rash—Stavudine—acquired immunodeficiency syndrome	0.000355	0.00197	CcSEcCtD
Argatroban—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000355	0.00197	CcSEcCtD
Argatroban—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000354	0.00197	CcSEcCtD
Argatroban—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000354	0.00196	CcSEcCtD
Argatroban—Headache—Stavudine—acquired immunodeficiency syndrome	0.000353	0.00196	CcSEcCtD
Argatroban—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000353	0.00196	CcSEcCtD
Argatroban—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000352	0.00195	CcSEcCtD
Argatroban—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000352	0.00195	CcSEcCtD
Argatroban—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000352	0.00195	CcSEcCtD
Argatroban—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000352	0.00195	CcSEcCtD
Argatroban—Rash—Abacavir—acquired immunodeficiency syndrome	0.00035	0.00194	CcSEcCtD
Argatroban—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000349	0.00194	CcSEcCtD
Argatroban—Headache—Abacavir—acquired immunodeficiency syndrome	0.000347	0.00193	CcSEcCtD
Argatroban—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000347	0.00193	CcSEcCtD
Argatroban—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000346	0.00192	CcSEcCtD
Argatroban—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000342	0.0019	CcSEcCtD
Argatroban—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00034	0.00189	CcSEcCtD
Argatroban—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00034	0.00189	CcSEcCtD
Argatroban—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.00188	CcSEcCtD
Argatroban—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000339	0.00188	CcSEcCtD
Argatroban—F2—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000338	0.0181	CbGpPWpGaD
Argatroban—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000336	0.00187	CcSEcCtD
Argatroban—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000335	0.00186	CcSEcCtD
Argatroban—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000335	0.00186	CcSEcCtD
Argatroban—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000335	0.00186	CcSEcCtD
Argatroban—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000335	0.00186	CcSEcCtD
Argatroban—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000334	0.00186	CcSEcCtD
Argatroban—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000329	0.00183	CcSEcCtD
Argatroban—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000328	0.00182	CcSEcCtD
Argatroban—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000326	0.00181	CcSEcCtD
Argatroban—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000326	0.00181	CcSEcCtD
Argatroban—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000325	0.0018	CcSEcCtD
Argatroban—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000325	0.0018	CcSEcCtD
Argatroban—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000325	0.0018	CcSEcCtD
Argatroban—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000325	0.0018	CcSEcCtD
Argatroban—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000324	0.0018	CcSEcCtD
Argatroban—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000322	0.00179	CcSEcCtD
Argatroban—F2—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.000318	0.017	CbGpPWpGaD
Argatroban—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000317	0.00176	CcSEcCtD
Argatroban—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000316	0.00175	CcSEcCtD
Argatroban—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000313	0.00174	CcSEcCtD
Argatroban—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000313	0.00174	CcSEcCtD
Argatroban—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000313	0.00174	CcSEcCtD
Argatroban—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000311	0.00173	CcSEcCtD
Argatroban—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000311	0.00173	CcSEcCtD
Argatroban—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000311	0.00173	CcSEcCtD
Argatroban—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000311	0.00173	CcSEcCtD
Argatroban—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000308	0.00171	CcSEcCtD
Argatroban—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000308	0.00171	CcSEcCtD
Argatroban—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000307	0.00171	CcSEcCtD
Argatroban—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000306	0.0017	CcSEcCtD
Argatroban—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000303	0.00168	CcSEcCtD
Argatroban—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.00167	CcSEcCtD
Argatroban—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000302	0.00167	CcSEcCtD
Argatroban—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000301	0.00167	CcSEcCtD
Argatroban—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000301	0.00167	CcSEcCtD
Argatroban—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000301	0.00167	CcSEcCtD
Argatroban—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000299	0.00166	CcSEcCtD
Argatroban—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000299	0.00166	CcSEcCtD
Argatroban—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000299	0.00166	CcSEcCtD
Argatroban—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000294	0.00163	CcSEcCtD
Argatroban—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000291	0.00161	CcSEcCtD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00029	0.0155	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.00029	0.0155	CbGpPWpGaD
Argatroban—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000289	0.00161	CcSEcCtD
Argatroban—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000289	0.00161	CcSEcCtD
Argatroban—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000289	0.00161	CcSEcCtD
Argatroban—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000288	0.0016	CcSEcCtD
Argatroban—Rash—Indinavir—acquired immunodeficiency syndrome	0.000287	0.00159	CcSEcCtD
Argatroban—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000287	0.00159	CcSEcCtD
Argatroban—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000286	0.00158	CcSEcCtD
Argatroban—Headache—Indinavir—acquired immunodeficiency syndrome	0.000285	0.00158	CcSEcCtD
Argatroban—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000284	0.00158	CcSEcCtD
Argatroban—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000281	0.00156	CcSEcCtD
Argatroban—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.00155	CcSEcCtD
Argatroban—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000276	0.00153	CcSEcCtD
Argatroban—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000276	0.00153	CcSEcCtD
Argatroban—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.00152	CcSEcCtD
Argatroban—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000272	0.00151	CcSEcCtD
Argatroban—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000271	0.0015	CcSEcCtD
Argatroban—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000271	0.0015	CcSEcCtD
Argatroban—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00027	0.0015	CcSEcCtD
Argatroban—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.0015	CcSEcCtD
Argatroban—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000269	0.00149	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000267	0.0143	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000262	0.014	CbGpPWpGaD
Argatroban—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00145	CcSEcCtD
Argatroban—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.00144	CcSEcCtD
Argatroban—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.00144	CcSEcCtD
Argatroban—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.00144	CcSEcCtD
Argatroban—F2—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.000258	0.0138	CbGpPWpGaD
Argatroban—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000258	0.00143	CcSEcCtD
Argatroban—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.00143	CcSEcCtD
Argatroban—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000255	0.00142	CcSEcCtD
Argatroban—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.0014	CcSEcCtD
Argatroban—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00025	0.00139	CcSEcCtD
Argatroban—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000244	0.00136	CcSEcCtD
Argatroban—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.00134	CcSEcCtD
Argatroban—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00134	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000241	0.0129	CbGpPWpGaD
Argatroban—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00133	CcSEcCtD
Argatroban—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00024	0.00133	CcSEcCtD
Argatroban—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.00133	CcSEcCtD
Argatroban—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.00132	CcSEcCtD
Argatroban—F2—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000236	0.0126	CbGpPWpGaD
Argatroban—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00129	CcSEcCtD
Argatroban—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.00128	CcSEcCtD
Argatroban—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00128	CcSEcCtD
Argatroban—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000231	0.00128	CcSEcCtD
Argatroban—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.00127	CcSEcCtD
Argatroban—F2—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000227	0.0122	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000227	0.0122	CbGpPWpGaD
Argatroban—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.00125	CcSEcCtD
Argatroban—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00123	CcSEcCtD
Argatroban—F2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000221	0.0118	CbGpPWpGaD
Argatroban—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.00122	CcSEcCtD
Argatroban—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.00122	CcSEcCtD
Argatroban—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.00121	CcSEcCtD
Argatroban—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.00121	CcSEcCtD
Argatroban—F2—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.000209	0.0112	CbGpPWpGaD
Argatroban—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.00115	CcSEcCtD
Argatroban—F2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000205	0.011	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.0002	0.0107	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	0.000191	0.0102	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.000188	0.01	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000187	0.01	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000187	0.01	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000179	0.00959	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000173	0.00925	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000162	0.00868	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000156	0.00833	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000153	0.00817	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000152	0.00816	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000152	0.00816	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.000151	0.00811	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.000151	0.00807	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000136	0.0073	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000123	0.00661	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000123	0.00659	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000121	0.00649	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000116	0.00621	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000116	0.00621	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000116	0.00621	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000113	0.00607	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00011	0.00592	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000104	0.00559	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000102	0.00549	CbGpPWpGaD
Argatroban—F2—Hemostasis—IFNA1—acquired immunodeficiency syndrome	9.93e-05	0.00532	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	9.82e-05	0.00526	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	9.78e-05	0.00524	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	8.82e-05	0.00473	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	7.97e-05	0.00427	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	7.95e-05	0.00426	CbGpPWpGaD
Argatroban—F2—Hemostasis—CSF2—acquired immunodeficiency syndrome	7.77e-05	0.00416	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7e-05	0.00375	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	6.97e-05	0.00373	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	6.69e-05	0.00358	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	6.69e-05	0.00358	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	6.55e-05	0.00351	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	6.55e-05	0.00351	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	6.33e-05	0.00339	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.05e-05	0.00324	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.95e-05	0.00319	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.95e-05	0.00319	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TAT—acquired immunodeficiency syndrome	5.42e-05	0.00291	CbGpPWpGaD
Argatroban—F2—Hemostasis—ALB—acquired immunodeficiency syndrome	5.06e-05	0.00271	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.99e-05	0.00267	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.91e-05	0.00263	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	4.79e-05	0.00256	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AGPS—acquired immunodeficiency syndrome	4.61e-05	0.00247	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.53e-05	0.00242	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.49e-05	0.00241	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.46e-05	0.00239	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.13e-05	0.00221	CbGpPWpGaD
Argatroban—F2—Hemostasis—IL2—acquired immunodeficiency syndrome	4.11e-05	0.0022	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.08e-05	0.00218	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.74e-05	0.002	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.52e-05	0.00188	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.52e-05	0.00188	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.67e-05	0.00143	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.63e-05	0.00141	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.6e-05	0.00139	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.52e-05	0.00135	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.41e-05	0.00129	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.36e-05	0.00126	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	2.14e-05	0.00115	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.39e-05	0.000746	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.39e-05	0.000742	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	9.46e-06	0.000507	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.18e-06	0.000438	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	4.4e-06	0.000236	CbGpPWpGaD
